$CYDY
CytoDyn Inc. Stock $cydy

$cydy Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000155837022013680 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$0.00	$0.00	$0.00
YoY Change	-100.0%
Cost Of Revenue	$2.704M	$73.49M	$0.00
YoY Change	270300.0%
Gross Profit	-$2.704M	-$73.49M	$0.00
YoY Change	-6860.0%
Gross Profit Margin
Selling, General & Admin	$6.333M	$10.34M	$10.14M
YoY Change	-16.86%	15.02%	28.32%
% of Gross Profit
Research & Development	$576.0K	-$4.909M	$9.128M
YoY Change	-95.82%	-134.16%	-25.93%
% of Gross Profit
Depreciation & Amortization	$99.00K	$124.0K	$129.0K
YoY Change	-64.13%	-54.91%	-74.76%
% of Gross Profit
Operating Expenses	$576.0K	$5.558M	$9.128M
YoY Change	-95.82%	-76.49%	-25.93%
Operating Profit	-$9.712M	-$79.05M	-$19.40M
YoY Change	-55.11%		-36.99%
Interest Expense	-$10.34M	-$2.216M	-$2.797M
YoY Change	223.7%	-12.24%	-58.85%
% of Operating Profit
Other Income/Expense, Net	-$940.0K	-$945.0K	-$7.025M
YoY Change	2585.71%		-702600.0%
Pretax Income	-$20.99M	-$110.4M	-$41.29M
YoY Change	-53.7%	146.0%	9.86%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$20.99M	-$110.4M	-$41.29M
YoY Change	-53.7%	146.0%	9.86%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.03		-$0.06
Diluted Earnings Per Share	-$0.03	-$153.9K	-$0.06
COMMON SHARES
Basic Shares Outstanding	810.7M		695.6K
Diluted Shares Outstanding	787.9M		695.6K

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.676M	$4.231M	$1.363M
YoY Change	-28.42%	-87.53%	-90.46%
Cash & Equivalents	$4.676M	$4.231M	$1.363M
Short-Term Investments
Other Short-Term Assets	$5.181M	$6.284M	$8.318M
YoY Change	11.32%	191.06%	174.79%
Inventory	$17.93M	$17.93M	$82.67M
Prepaid Expenses	$4.143M	$5.198M	$6.135M
Receivables
Other Receivables
Total Short-Term Assets	$9.857M	$10.52M	$92.35M
YoY Change	-90.41%	-70.87%	-16.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$502.0K	$73.00K	$117.0K
YoY Change	289.15%	-45.52%	-5.65%
Goodwill
YoY Change
Intangibles		$132.0K	$1.043M
YoY Change		-92.01%	-45.54%
Long-Term Investments
YoY Change
Other Assets	$608.0K	$741.0K
YoY Change
Total Long-Term Assets	$18.54M	$18.67M	$1.730M
YoY Change	748.76%	-80.55%	-38.19%
TOTAL ASSETS
Total Short-Term Assets	$9.857M	$10.52M	$92.35M
Total Long-Term Assets	$18.54M	$18.67M	$1.730M
Total Assets	$28.39M	$29.19M	$94.08M
YoY Change	-72.95%	-77.9%	-17.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$69.00M	$68.00M	$62.40M
YoY Change	4.7%	3.19%	-13.94%
Accrued Expenses	$16.50M	$18.95M	$18.05M
YoY Change	33.41%	-20.73%	-1.8%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$36.83M	$36.24M	$35.65M
YoY Change	-28.25%	-42.24%	-6.13%
Total Short-Term Liabilities	$122.3M	$123.2M	$116.1M
YoY Change	-5.65%	-19.26%	-9.91%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$387.0K	$422.0K	$453.0K
YoY Change	-25.43%	-23.55%	-22.96%
Total Long-Term Liabilities	$387.0K	$422.0K	$453.0K
YoY Change	-25.43%	-23.55%	-22.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$122.3M	$123.2M	$116.1M
Total Long-Term Liabilities	$387.0K	$422.0K	$453.0K
Total Liabilities	$122.7M	$123.6M	$116.5M
YoY Change	-5.73%	-19.28%	-9.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$782.9M	-$766.1M	-$681.6M
YoY Change	30.6%	38.37%	41.07%
Common Stock	$813.0K	$720.0K	$713.0K
YoY Change	26.24%	15.02%	17.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$94.31M	-$94.40M	-$22.46M
YoY Change
Total Liabilities & Shareholders Equity	$28.39M	$29.19M	$94.08M
YoY Change	-72.95%	-77.9%	-17.22%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$20.99M	-$110.4M	-$41.29M
YoY Change	-53.7%	146.0%	9.86%
Depreciation, Depletion And Amortization	$99.00K	$124.0K	$129.0K
YoY Change	-64.13%	-54.91%	-74.76%
Cash From Operating Activities	-$11.07M	-$6.044M	-$11.05M
YoY Change	-65.11%	-81.58%	-53.29%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$30.00K	-$17.00K
YoY Change	-100.0%	-236.36%	-26.09%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$30.00K	-$17.00K
YoY Change	-100.0%	-236.36%	-26.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	11.52M	7.882M	4.552M
YoY Change	164.93%	-84.98%	-46.79%
NET CHANGE
Cash From Operating Activities	-11.07M	-6.044M	-11.05M
Cash From Investing Activities	0.000	30.00K	-17.00K
Cash From Financing Activities	11.52M	7.882M	4.552M
Net Change In Cash	445.0K	1.868M	-6.512M
YoY Change	-101.62%	-90.49%	-56.92%
FREE CASH FLOW
Cash From Operating Activities	-$11.07M	-$6.044M	-$11.05M
Capital Expenditures	$0.00	$30.00K	-$17.00K
Free Cash Flow	-$11.07M	-$6.074M	-$11.03M
YoY Change	-65.12%	-81.47%	-53.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	676900000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	587590000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	421078000
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001175680
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	676900000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	587590000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	421078000
CY2022	dei	Entity Registrant Name EntityRegistrantName	CytoDyn Inc.
CY2022Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue
CY2021Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2022Q2	cydy	Number Of Warrants In Fixed Combination Issue Of Securities NumberOfWarrantsInFixedCombinationIssueOfSecurities	0.3
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-05-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-49908
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-1887078
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1111 Main Street, Suite 660
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Vancouver
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98660
CY2022	dei	City Area Code CityAreaCode	360
CY2022	dei	Local Phone Number LocalPhoneNumber	980-8524
CY2022	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2022	dei	Security12g Title Security12gTitle	Common Stock, par value $0.001 per share
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Public Float EntityPublicFloat	841543090
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	810720424
CY2021	dei	Auditor Firm AuditorFirmId	2226
CY2022	dei	Auditor Firm AuditorFirmId	324
CY2021	dei	Auditor Name AuditorName	Warren Averett, LLC
CY2021	dei	Auditor Location AuditorLocation	Birmingham, Alabama
CY2022	dei	Auditor Name AuditorName	Macias Gini & O’Connell LLP
CY2022	dei	Auditor Location AuditorLocation	San Jose, California
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	87000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4231000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33943000
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5198000
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	616000
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	36241000
CY2021Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	62747000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	123161000
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	152546000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	422000
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	552000
CY2022Q2	us-gaap	Liabilities Liabilities	123583000
CY2021Q2	us-gaap	Liabilities Liabilities	153098000
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	cydy	Prepaid Service Fees Current PrepaidServiceFeesCurrent	1086000
CY2021Q2	cydy	Prepaid Service Fees Current PrepaidServiceFeesCurrent	1543000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	10515000
CY2021Q2	us-gaap	Assets Current AssetsCurrent	36102000
CY2022Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	17929000
CY2021Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	93479000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	536000
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	712000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	73000
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	134000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	132000
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1653000
CY2022Q2	us-gaap	Assets Assets	29185000
CY2021Q2	us-gaap	Assets Assets	132080000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	67974000
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	65897000
CY2022Q2	cydy	Accrued Compensation And Non Financing Liabilities AccruedCompensationAndNonFinancingLiabilities	8861000
CY2021Q2	cydy	Accrued Compensation And Non Financing Liabilities AccruedCompensationAndNonFinancingLiabilities	19073000
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	5974000
CY2021Q2	us-gaap	Interest Payable Current InterestPayableCurrent	2007000
CY2022Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	3977000
CY2021Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	2647000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	134000
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	175000
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	720028000
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	626123000
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	719585000
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	625680000
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	720000
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	626000
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	671013000
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	532031000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-766131000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-553675000
CY2021Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	443000
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	443000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	404000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-94398000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-21018000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29185000
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	132080000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	266000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	53000
CY2022	us-gaap	Gross Profit GrossProfit	213000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	44303000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34320000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19973000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27043000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	53403000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	52640000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	781000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1797000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2034000
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	10049000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	73490000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	5027000
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	145617000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	104596000
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	74647000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-145404000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-104596000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-74647000
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	5417000
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	4387000
CY2020	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	7330000
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2958000
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3591000
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1645000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	87000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	65000
CY2022	cydy	Gain Loss On Induced Conversion Of Debt GainLossOnInducedConversionOfDebt	37381000
CY2021	cydy	Gain Loss On Induced Conversion Of Debt GainLossOnInducedConversionOfDebt	39131000
CY2022	cydy	Finance Charge Adjustments FinanceChargeAdjustments	9029000
CY2021	cydy	Finance Charge Adjustments FinanceChargeAdjustments	145000
CY2020	cydy	Finance Charge Adjustments FinanceChargeAdjustments	431000
CY2022	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	6691000
CY2021	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	13922000
CY2020	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	23437000
CY2022	cydy	Non Operating Legal Settlement Expense NonOperatingLegalSettlementExpense	-3853000
CY2021	cydy	Non Operating Legal Settlement Expense NonOperatingLegalSettlementExpense	-10628000
CY2020	cydy	Non Operating Legal Settlement Expense NonOperatingLegalSettlementExpense	-22500000
CY2020	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-9542000
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	65416000
CY2021	us-gaap	Interest And Debt Expense InterestAndDebtExpense	71869000
CY2020	us-gaap	Interest And Debt Expense InterestAndDebtExpense	65289000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-210820000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-176465000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-139936000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-210820000
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	68381000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-176465000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-139936000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	676900000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	587590000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	421078000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	-8913000
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	10822000
CY2020	cydy	Adjustments To Additional Paid In Capital Convertible Debt Fees AdjustmentsToAdditionalPaidInCapitalConvertibleDebtFees	-3899000
CY2020	cydy	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	20500000
CY2020	cydy	Adjustments To Additional Paid In Capital Relative Fair Market Value Associated With Warrant Exercised AdjustmentsToAdditionalPaidInCapitalRelativeFairMarketValueAssociatedWithWarrantExercised	11949000
CY2020	cydy	Inducement Interest Expense Related To Private Warrant Exchange InducementInterestExpenseRelatedToPrivateWarrantExchange	20724000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13409000
CY2020	cydy	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Excluding Legal Fees AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsExcludingLegalFees	437000
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	8000
CY2020	us-gaap	Dividends Preferred Stock DividendsPreferredStock	945000
CY2020	cydy	Adjustments To Additional Paid In Capital Legal Fees In Connection With Equity Offering AdjustmentsToAdditionalPaidInCapitalLegalFeesInConnectionWithEquityOffering	16000
CY2020	cydy	Stock Issued For Incentive Compensation And Tendered For Income Tax Value StockIssuedForIncentiveCompensationAndTenderedForIncomeTaxValue	154000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5603000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6548000
CY2020	cydy	Issuance Of Stock Value Legal Settlement IssuanceOfStockValueLegalSettlement	22500000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-139936000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-2481000
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	96938000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1838000
CY2021	cydy	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	18649000
CY2021	cydy	Inducement Interest Expense Related To Private Warrant Exchange InducementInterestExpenseRelatedToPrivateWarrantExchange	13922000
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1909000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9601000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-176465000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-21018000
CY2022	cydy	Issuance Of Stock Value Legal Settlement IssuanceOfStockValueLegalSettlement	2863000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	390000
CY2022	cydy	Stock Issued For Incentive Compensation And Tendered For Income Tax Value StockIssuedForIncentiveCompensationAndTenderedForIncomeTaxValue	668000
CY2022	cydy	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Excluding Legal Fees AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsExcludingLegalFees	5316000
CY2022	cydy	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1036000
CY2022	cydy	Inducement Interest Expense Related To Private Warrant Exchange InducementInterestExpenseRelatedToPrivateWarrantExchange	6691000
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1330000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5571000
CY2022	cydy	Adjustments To Additional Paid In Capital Warrant Issuance Cost AdjustmentsToAdditionalPaidInCapitalWarrantIssuanceCost	6585000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-210820000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-94398000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-210820000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-176465000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-139936000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	65000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	404000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	781000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1797000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2034000
CY2020	cydy	Payment Of Debt Conversion Offering Costs PaymentOfDebtConversionOfferingCosts	2303000
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	243000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-77723000
CY2021	cydy	Payments For Warrant Tender Offer Held In Trust PaymentsForWarrantTenderOfferHeldInTrust	10000
CY2020	cydy	Payments For Warrant Tender Offer Held In Trust PaymentsForWarrantTenderOfferHeldInTrust	844000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	390000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1839000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-117573000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-68804000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5602000
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2958000
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3591000
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1645000
CY2022	cydy	Adjustment To Reconcile Net Loss To Net Cash Used In Operating Activities Litigation Settlement AdjustmentToReconcileNetLossToNetCashUsedInOperatingActivitiesLitigationSettlement	3663000
CY2020	cydy	Adjustment To Reconcile Net Loss To Net Cash Used In Operating Activities Litigation Settlement AdjustmentToReconcileNetLossToNetCashUsedInOperatingActivitiesLitigationSettlement	22500000
CY2022	cydy	Finance Charges Related To Surety Bond FinanceChargesRelatedToSuretyBond	6585000
CY2022	cydy	Gain Loss On Induced Conversion Of Debt GainLossOnInducedConversionOfDebt	37381000
CY2021	cydy	Gain Loss On Induced Conversion Of Debt GainLossOnInducedConversionOfDebt	39131000
CY2022	cydy	Inducement Interest Expense And Non Cash Finance Charges InducementInterestExpenseAndNonCashFinanceCharges	6691000
CY2021	cydy	Inducement Interest Expense And Non Cash Finance Charges InducementInterestExpenseAndNonCashFinanceCharges	13922000
CY2020	cydy	Inducement Interest Expense And Non Cash Finance Charges InducementInterestExpenseAndNonCashFinanceCharges	23437000
CY2020	cydy	Interest Expense Related To Accretion Of Convertible Notes Payable InterestExpenseRelatedToAccretionOfConvertibleNotesPayable	6615000
CY2020	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-9542000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	73490000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	5027000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	6239000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	10429000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	6548000
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	10049000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2060000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	79359000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19147000
CY2020	cydy	Increase Decrease In Miscellaneous Receivable IncreaseDecreaseInMiscellaneousReceivable	-91000
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4125000
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1228000
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1577000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2713000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	53012000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	19040000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	122000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	41000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-122000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41000
CY2022	cydy	Proceeds From Warrant Transactions Net ProceedsFromWarrantTransactionsNet	5390000
CY2021	cydy	Proceeds From Warrant Transactions Net ProceedsFromWarrantTransactionsNet	17060000
CY2022	cydy	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	41195000
CY2021	cydy	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	1000000
CY2020	cydy	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	12666000
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1036000
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	19428000
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	38422000
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	13409000
CY2020	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	8000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	950000
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2185000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	525000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	778000
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	89000
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	100000000
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	15000000
CY2022	cydy	Stock Issued During Period Non Cash Value Warrant Exercised StockIssuedDuringPeriodNonCashValueWarrantExercised	1000
CY2021	cydy	Stock Issued During Period Non Cash Value Warrant Exercised StockIssuedDuringPeriodNonCashValueWarrantExercised	11000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	48011000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	137346000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	79670000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-29712000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19651000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10825000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33943000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14292000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3467000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4231000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33943000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14292000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4231000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33943000
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14282000
CY2020Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4231000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33943000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14292000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	63000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	147000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	243000
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	31000000
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	57807000
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	15092000
CY2022	cydy	Dividends On Convertible Preferred Stock Incurred But Not Yet Paid. DividendsOnConvertiblePreferredStockIncurredButNotYetPaid.	1636000
CY2021	cydy	Dividends On Convertible Preferred Stock Incurred But Not Yet Paid. DividendsOnConvertiblePreferredStockIncurredButNotYetPaid.	1666000
CY2020	cydy	Dividends On Convertible Preferred Stock Incurred But Not Yet Paid. DividendsOnConvertiblePreferredStockIncurredButNotYetPaid.	944000
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 6pt 0pt;"><i style="font-style:italic;font-weight:normal;">Reclassifications</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">Certain prior year amounts shown in the accompanying consolidated financial statements have been reclassified to conform to the current period presentation. Such reclassifications did not have material effect, if any, on the Company’s previously reported financial position, results of operations, stockholders’ (deficit) equity, or net cash provided by operating activities.</p>
CY2020	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	23437000
CY2020	cydy	Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt	65289000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-139936000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-139936000
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2020Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	372301000
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-375301000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	15533000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	4532000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300000
CY2021Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0
CY2022Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-210800000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-176500000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-139900000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-766100000
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 6pt 0pt;"><i style="font-style:italic;font-weight:normal;">Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, and the disclosure of contingent assets and liabilities at the date of consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are assessed and updated each period to reflect current information, such as the status of our analysis of the clinical trial results and discussions with the FDA which could have an impact on the Company’s significant accounting estimates and assumptions. The Company’s estimates are based on historical experience and on various market and other relevant, appropriate assumptions. Significant estimates include, but are not limited, to those relating to capitalization of pre-launch inventories including reserves and write-offs for excess and obsolete inventories, stock-based compensation, commitments and contingencies, assumptions used to value warrants including warrant modifications and inducements, and research and development expenses. Actual results could differ from these estimates.</p>
CY2022Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	4000000.0
CY2021Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	33700000
CY2021Q2	cydy	Number Of Counterparties NumberOfCounterparties	2
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	10000000.0
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	73500000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0
CY2022Q2	cydy	Number Of Counterparties NumberOfCounterparties	2
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0
CY2020	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0
CY2021	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0
CY2022	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	10200000
CY2022	cydy	Inventory Number Of Batches Not Saleable InventoryNumberOfBatchesNotSaleable	5
CY2022	cydy	Total Number Of Batches Not Saleable TotalNumberOfBatchesNotSaleable	9
CY2022Q2	cydy	Inventory With Shelf Life Less Than One Year InventoryWithShelfLifeLessThanOneYear	6903000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022Q2	cydy	Inventory Raw Material Noncurrent InventoryRawMaterialNoncurrent	16264000
CY2021Q2	cydy	Inventory Raw Material Noncurrent InventoryRawMaterialNoncurrent	28085000
CY2022Q2	cydy	Inventory Work In Progress Noncurrent InventoryWorkInProgressNoncurrent	1665000
CY2021Q2	cydy	Inventory Work In Progress Noncurrent InventoryWorkInProgressNoncurrent	65394000
CY2022Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	17929000
CY2021Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	93479000
CY2022Q2	cydy	Inventory With Shelf Life From One To Two Years InventoryWithShelfLifeFromOneToTwoYears	20201000
CY2022Q2	cydy	Inventory With Shelf Life From Two To Three Years InventoryWithShelfLifeFromTwoToThreeYears	31241000
CY2022Q2	cydy	Inventory With Shelf Life From Three To Four Years InventoryWithShelfLifeFromThreeToFourYears	33075000
CY2022Q2	cydy	Inventory Gross Noncurrent InventoryGrossNoncurrent	91420000
CY2022Q2	cydy	Inventory Write Off Noncurrent InventoryWriteOffNoncurrent	73491000
CY2022Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	17929000
CY2021Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2598000
CY2022Q2	cydy	Accrued Compensation And Non Financing Liabilities AccruedCompensationAndNonFinancingLiabilities	8861000
CY2021Q2	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	10600000
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	65900000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3520000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6446000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3388000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4793000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	132000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1653000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1800000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000.0
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	10000000.0
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	132000.0
CY2022Q2	cydy	Finite Lived Intangible Assets Amortization Expense Thereafter FiniteLivedIntangibleAssetsAmortizationExpenseThereafter	0
CY2021Q1	cydy	Acquisition Of Intangible Asset Shares Subject To Arbitration AcquisitionOfIntangibleAssetSharesSubjectToArbitration	3100000
CY2021Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	10000000.0
CY2021Q1	cydy	Impairment Of Intangible Assets Portion Charged Against Original Cost ImpairmentOfIntangibleAssetsPortionChargedAgainstOriginalCost	12200000
CY2021Q1	cydy	Impairment Of Intangible Assets Reversal Of Accumulated Amortization ImpairmentOfIntangibleAssetsReversalOfAccumulatedAmortization	2200000
CY2022Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	800000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	68000000.0
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1504000
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4005000
CY2022Q2	us-gaap	Litigation Reserve Current LitigationReserveCurrent	2006000
CY2021Q2	us-gaap	Litigation Reserve Current LitigationReserveCurrent	11008000
CY2022Q2	cydy	Accrued Clinical Expenses AccruedClinicalExpenses	3727000
CY2021Q2	cydy	Accrued Clinical Expenses AccruedClinicalExpenses	1462000
CY2021Q2	cydy	Accrued Compensation And Non Financing Liabilities AccruedCompensationAndNonFinancingLiabilities	19073000
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1624000
CY2021	cydy	Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.66
CY2021Q2	cydy	Stock Options And Warrants Outstanding Numbers StockOptionsAndWarrantsOutstandingNumbers	60774000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-766100000
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	38319000
CY2021Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	70500000
CY2022Q2	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	2078000
CY2021Q2	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	7753000
CY2022Q2	cydy	Long Term Debt Including Accrued Interest LongTermDebtIncludingAccruedInterest	36241000
CY2021Q2	cydy	Long Term Debt Including Accrued Interest LongTermDebtIncludingAccruedInterest	62747000
CY2022Q2	cydy	Accrued Interest Noncurrent AccruedInterestNoncurrent	5974000
CY2021Q2	cydy	Accrued Interest Noncurrent AccruedInterestNoncurrent	2007000
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	42215000
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	64754000
CY2021Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	64754000
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3045000
CY2022	cydy	Interest Expense Accrued InterestExpenseAccrued	5417000
CY2022	cydy	Debt Conversion Fair Market Value Of Shares Exchanged For Repayment DebtConversionFairMarketValueOfSharesExchangedForRepayment	42073000
CY2022	cydy	Changes In Fair Value Of Common Stocks Of Convertible Debt ChangesInFairValueOfCommonStocksOfConvertibleDebt	-11072000
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	42215000
CY2021Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	3400000
CY2020Q2	cydy	Stock Options And Warrants Outstanding Numbers StockOptionsAndWarrantsOutstandingNumbers	130561000
CY2020Q2	cydy	Stock Options And Warrants Outstanding Weighted Average Exercise Price StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice	0.65
CY2020	cydy	Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm	P5Y9M14D
CY2020Q2	cydy	Stock Options And Warrants Outstanding Aggregate Intrinsic Value StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue	896000
CY2021	cydy	Stock Options And Warrants Grants In Period StockOptionsAndWarrantsGrantsInPeriod	7036000
CY2021	cydy	Stock Options And Warrants Grants In Period Weighted Average Exercise Price StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice	3.82
CY2021	cydy	Stock Options And Warrants Exercised In Period StockOptionsAndWarrantsExercisedInPeriod	75735000
CY2021	cydy	Stock Options And Warrants Exercised In Period Weighted Average Exercise Price StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice	0.59
CY2021	cydy	Stock Options And Warrants Forfeitures And Expirations In Period StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod	1088000
CY2021Q2	cydy	Stock Options And Warrants Outstanding Weighted Average Exercise Price StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice	0.95
CY2021	cydy	Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm	P4Y4M13D
CY2021Q2	cydy	Stock Options And Warrants Outstanding Aggregate Intrinsic Value StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue	68061000
CY2022	cydy	Stock Options And Warrants Grants In Period StockOptionsAndWarrantsGrantsInPeriod	50205000
CY2022	cydy	Stock Options And Warrants Grants In Period Weighted Average Exercise Price StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice	0.72
CY2022	cydy	Stock Options And Warrants Exercised In Period StockOptionsAndWarrantsExercisedInPeriod	5677000
CY2022	cydy	Stock Options And Warrants Exercised In Period Weighted Average Exercise Price StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice	0.71
CY2022	cydy	Stock Options And Warrants Forfeitures And Expirations In Period StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod	14597000
CY2022	cydy	Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.36
CY2022Q2	cydy	Stock Options And Warrants Outstanding Numbers StockOptionsAndWarrantsOutstandingNumbers	90705000
CY2022Q2	cydy	Stock Options And Warrants Outstanding Weighted Average Exercise Price StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice	0.77
CY2022	cydy	Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm	P4Y21D
CY2022Q2	cydy	Stock Options And Warrants Outstanding Aggregate Intrinsic Value StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue	352000
CY2022Q2	cydy	Stock Options And Warrants Outstanding Exercisable Number StockOptionsAndWarrantsOutstandingExercisableNumber	82918000
CY2022Q2	cydy	Stock Options And Warrants Outstanding Exercisable Weighted Average Exercise Price StockOptionsAndWarrantsOutstandingExercisableWeightedAverageExercisePrice	0.69
CY2022	cydy	Stock Options And Warrants Outstanding Exercisable Weighted Average Remaining Contractual Term StockOptionsAndWarrantsOutstandingExercisableWeightedAverageRemainingContractualTerm	P3Y7M9D
CY2022Q2	cydy	Stock Options And Warrants Outstanding Exercisable Aggregate Intrinsic Value StockOptionsAndWarrantsOutstandingExercisableAggregateIntrinsicValue	352000
CY2022	cydy	Stock Options And Warrants Exercised In Period StockOptionsAndWarrantsExercisedInPeriod	5677000
CY2021	cydy	Stock Options And Warrants Exercised In Period StockOptionsAndWarrantsExercisedInPeriod	75735000
CY2020	cydy	Stock Options And Warrants Exercised In Period StockOptionsAndWarrantsExercisedInPeriod	101853000
CY2022	cydy	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	6816000
CY2021	cydy	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	38327000
CY2020	cydy	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	44024000
CY2022Q2	cydy	Stock Options And Warrants Exercised Aggregate Intrinsic Value StockOptionsAndWarrantsExercisedAggregateIntrinsicValue	5815000
CY2021Q2	cydy	Stock Options And Warrants Exercised Aggregate Intrinsic Value StockOptionsAndWarrantsExercisedAggregateIntrinsicValue	298891000
CY2020Q2	cydy	Stock Options And Warrants Exercised Aggregate Intrinsic Value StockOptionsAndWarrantsExercisedAggregateIntrinsicValue	112145000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.943
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.220
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.803
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.278
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.928
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	1.0489
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.8486
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.5229
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0167
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	587590000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	421078000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0045
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0146
CY2022	cydy	Share Based Compensation Number Of Active Plans ShareBasedCompensationNumberOfActivePlans	1
CY2022	cydy	Share Based Compensation Number Of Inactive Plans ShareBasedCompensationNumberOfInactivePlans	1
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	500000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	400000
CY2022Q2	cydy	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfSharesOutstanding	9900000
CY2021Q2	cydy	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfSharesOutstanding	12800000
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	7500000
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	5800000
CY2020Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1600000
CY2021	cydy	Stock Issued Upon Vesting Of Stock Based Compensation Awards Shares StockIssuedUponVestingOfStockBasedCompensationAwardsShares	200000
CY2021	cydy	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	26700000
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	7900000
CY2022	cydy	Class Of Warrant Covering Common Stock Shares Purchased Percentage ClassOfWarrantCoveringCommonStockSharesPurchasedPercentage	0.12
CY2022	cydy	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	1400000
CY2022	cydy	Stock Issued During Period Value Warrants Exercised Cash StockIssuedDuringPeriodValueWarrantsExercisedCash	1000000.0
CY2022	cydy	Stock Issued During Period Non Cash Shares Warrant Exercised StockIssuedDuringPeriodNonCashSharesWarrantExercised	200000
CY2022	cydy	Warrants Exercised Noncash Number Of Warrants WarrantsExercisedNoncashNumberOfWarrants	300000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-210820000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-176465000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-139936000
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	-1628000
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	-1687000
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	-708000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-212448000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-178152000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-140644000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	676900000
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	cydy	Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent	0
CY2021	cydy	Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent	0
CY2020	cydy	Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent	-0.016
CY2022	cydy	Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Issuance Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtIssuanceCostsPercent	0
CY2021	cydy	Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Issuance Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtIssuanceCostsPercent	0
CY2020	cydy	Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Issuance Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtIssuanceCostsPercent	-0.001
CY2022	cydy	Effective Income Tax Rate Reconciliation Nondeductible Expense Interest EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest	-0.005
CY2021	cydy	Effective Income Tax Rate Reconciliation Nondeductible Expense Interest EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest	-0.006
CY2020	cydy	Effective Income Tax Rate Reconciliation Nondeductible Expense Interest EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest	-0.012
CY2022	cydy	Effective Income Tax Rate Reconciliation Inducement Charge EffectiveIncomeTaxRateReconciliationInducementCharge	-0.007
CY2021	cydy	Effective Income Tax Rate Reconciliation Inducement Charge EffectiveIncomeTaxRateReconciliationInducementCharge	-0.015
CY2020	cydy	Effective Income Tax Rate Reconciliation Inducement Charge EffectiveIncomeTaxRateReconciliationInducementCharge	-0.013
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.011
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.003
CY2022	cydy	Effective Income Tax Rate Reconciliation Tax Credit Carryforward EffectiveIncomeTaxRateReconciliationTaxCreditCarryforward	-0.002
CY2021	cydy	Effective Income Tax Rate Reconciliation Tax Credit Carryforward EffectiveIncomeTaxRateReconciliationTaxCreditCarryforward	-0.001
CY2020	cydy	Effective Income Tax Rate Reconciliation Tax Credit Carryforward EffectiveIncomeTaxRateReconciliationTaxCreditCarryforward	-0.001
CY2022	cydy	Effective Income Tax Rate Reconciliation Nondeductible Expense Loss On Induced Conversion Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLossOnInducedConversionPercent	-0.037
CY2021	cydy	Effective Income Tax Rate Reconciliation Nondeductible Expense Loss On Induced Conversion Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLossOnInducedConversionPercent	-0.026
CY2020	cydy	Effective Income Tax Rate Reconciliation Nondeductible Expense Loss On Induced Conversion Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLossOnInducedConversionPercent	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	-0.003
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	-0.006
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	-0.003
CY2022	cydy	Effective Income Tax Rate Reconciliation Non Deductible Expense Irc162 Limitation EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseIrc162Limitation	-0.001
CY2021	cydy	Effective Income Tax Rate Reconciliation Non Deductible Expense Irc162 Limitation EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseIrc162Limitation	-0.011
CY2020	cydy	Effective Income Tax Rate Reconciliation Non Deductible Expense Irc162 Limitation EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseIrc162Limitation	-0.024
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.017
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.032
CY2022	cydy	Effective Income Tax Rate Reconciliation Nondeductible Expense On Induced Conversion Of Debt EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOnInducedConversionOfDebt	-0.003
CY2021	cydy	Effective Income Tax Rate Reconciliation Nondeductible Expense On Induced Conversion Of Debt EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOnInducedConversionOfDebt	-0.012
CY2020	cydy	Effective Income Tax Rate Reconciliation Nondeductible Expense On Induced Conversion Of Debt EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOnInducedConversionOfDebt	-0.038
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.163
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.150
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.131
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83254000
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	106965000
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	74258000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2063000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2063000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	6057000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	5510000
CY2022Q2	cydy	Charitable Contribution Carry Forward CharitableContributionCarryForward	14000
CY2021Q2	cydy	Charitable Contribution Carry Forward CharitableContributionCarryForward	14000
CY2022Q2	cydy	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Vacation And Payroll Expenses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedVacationAndPayrollExpenses	68000
CY2021Q2	cydy	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Vacation And Payroll Expenses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedVacationAndPayrollExpenses	87000
CY2022Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	0
CY2021Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	3000
CY2022Q2	cydy	Deferred Tax Liability Right Of Use Asset DeferredTaxLiabilityRightOfUseAsset	112000
CY2021Q2	cydy	Deferred Tax Liability Right Of Use Asset DeferredTaxLiabilityRightOfUseAsset	0
CY2022Q2	cydy	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	117000
CY2021Q2	cydy	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	0
CY2022Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	2138000
CY2021Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	146000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	89000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	874000
CY2022Q2	cydy	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	238000
CY2021Q2	cydy	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	396000
CY2022Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1000
CY2021Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0
CY2022Q2	cydy	Deferred Tax Assets Liability Difference In Acquired Assets DeferredTaxAssetsLiabilityDifferenceInAcquiredAssets	0
CY2021Q2	cydy	Deferred Tax Assets Liability Difference In Acquired Assets DeferredTaxAssetsLiabilityDifferenceInAcquiredAssets	91000
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	117638000
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	117638000
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	83254000
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	117638000
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83254000
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	509400000
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	352000000.0
CY2020Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	264700000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	200000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	300000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	536000
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	712000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	134000
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	175000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	422000
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	552000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	556000
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	727000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	177000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	182000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	185000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	208000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	752000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	196000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	556000
CY2021	cydy	Gain Loss On Induced Conversion Of Debt GainLossOnInducedConversionOfDebt	39131000
CY2021	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	13922000
CY2021	cydy	Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt	71869000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-176465000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-176465000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	532031000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-553675000
CY2020Q4	cydy	Gain Loss On Induced Conversion Of Debt GainLossOnInducedConversionOfDebt	6724000
	cydy	Gain Loss On Induced Conversion Of Debt GainLossOnInducedConversionOfDebt	6724000
CY2020Q4	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	4217000
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	7562000
CY2020Q4	cydy	Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt	13477000
	cydy	Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt	18637000
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37980000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-68812000
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-37980000
	us-gaap	Net Income Loss NetIncomeLoss	-68812000
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	438067000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	438067000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-445191000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-445191000
	cydy	Gain Loss On Induced Conversion Of Debt GainLossOnInducedConversionOfDebt	6724000
CY2021Q1	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	5360000
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	12922000
CY2021Q1	cydy	Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt	6796000
	cydy	Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt	25433000
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37581000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-106393000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-37581000
	us-gaap	Net Income Loss NetIncomeLoss	-106393000
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	466779000
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	466779000
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-483183000
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-483183000
CY2021Q3	cydy	Gain Loss On Induced Conversion Of Debt GainLossOnInducedConversionOfDebt	18530000
CY2021Q3	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	528000
CY2021Q3	cydy	Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt	23700000
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-45337000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-45337000
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	573595000
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-599432000
CY2021Q4	cydy	Gain Loss On Induced Conversion Of Debt GainLossOnInducedConversionOfDebt	6785000
	cydy	Gain Loss On Induced Conversion Of Debt GainLossOnInducedConversionOfDebt	25315000
CY2021Q4	cydy	Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt	14755000
	cydy	Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt	38455000
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40077000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-85414000
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-40077000
	us-gaap	Net Income Loss NetIncomeLoss	-85414000
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	626558000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	626558000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-639940000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-639940000
CY2022Q1	cydy	Gain Loss On Induced Conversion Of Debt GainLossOnInducedConversionOfDebt	12066000
	cydy	Gain Loss On Induced Conversion Of Debt GainLossOnInducedConversionOfDebt	37381000
CY2022Q1	cydy	Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt	21888000
	cydy	Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt	60343000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-41285000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-126699000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-41285000
	us-gaap	Net Income Loss NetIncomeLoss	-126699000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	658449000
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	658449000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-681622000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-681622000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	15533000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	4532000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	525000

Files In Submission

Name	View Source	Status
0001558370-22-013680-index-headers.html	Edgar Link	pending
0001558370-22-013680-index.html	Edgar Link	pending
0001558370-22-013680.txt	Edgar Link	pending
0001558370-22-013680-xbrl.zip	Edgar Link	pending
cydy-20220531.xsd	Edgar Link	pending
cydy-20220531x10k.htm	Edgar Link	pending
cydy-20220531x10k004.jpg	Edgar Link	pending
cydy-20220531x10k008.jpg	Edgar Link	pending
cydy-20220531xex10d10.htm	Edgar Link	pending
cydy-20220531xex10d25.htm	Edgar Link	pending
cydy-20220531xex10d28.htm	Edgar Link	pending
cydy-20220531xex10d7.htm	Edgar Link	pending
cydy-20220531xex10d8.htm	Edgar Link	pending
cydy-20220531xex10d9.htm	Edgar Link	pending
cydy-20220531x10k_htm.xml	Edgar Link	completed
cydy-20220531xex21.htm	Edgar Link	pending
cydy-20220531xex23d1.htm	Edgar Link	pending
cydy-20220531xex23d2.htm	Edgar Link	pending
cydy-20220531xex31d1.htm	Edgar Link	pending
cydy-20220531xex31d2.htm	Edgar Link	pending
cydy-20220531xex32.htm	Edgar Link	pending
cydy-20220531xex4d1.htm	Edgar Link	pending
cydy-20220531xex4d22.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
cydy-20220531_def.xml	Edgar Link	unprocessable
cydy-20220531_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cydy-20220531_pre.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cydy-20220531_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CYDY
CytoDyn Inc. Stock $cydy

2022 Q3 Form 10-K Financial Statement

#000155837022013680 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYDY CytoDyn Inc. Stock $cydy

2022 Q3 Form 10-K Financial Statement

#000155837022013680 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYDY
CytoDyn Inc. Stock $cydy